Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers
Laurel Northouse(University of Michigan), Trace Kershaw(Department of Health), Darlene Mood(Wayne State University), Peter C. Trask(Pfizer (United States)), Patricia LoRusso(Yale Cancer Center), Gregory P. Kalemkerian(University of Michigan), Daniel F. Hayes(University of Michigan–Ann Arbor), Ann Schafenacker(University of Michigan), A. Mark Fendrick(Ann Arbor Center for Independent Living), David L. Ronis(Ann Arbor VA Medical Center), Maha Hussain, John Ruckdeschel(University of Nevada, Las Vegas), Mark M. Zalupski(University of Michigan)
Cited by 238
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k